GlobeNewswire by notified

Convening of annual general meeting of Nykredit Realkredit A/S

Share

To Nasdaq Copenhagen

9 March 2023

ConveningofannualgeneralmeetingofNykreditRealkreditA/S

Nykredit Realkredit A/S will hold its annual general meeting on Thursday, 23 March 2023 at 12:00 noon at the Company's offices at Kalvebod Brygge 1-3, DK-1560 Copenhagen V.

-o0o-

Agenda:

  1. The Directors' report on the Company's activities in the past year.

  2. Presentation of the Annual Report 2022 for approval and resolution on the discharge of the Board of Directors and the Executive Board.

  3. Proposal for the appropriation of profit according to the approved Annual Report.

  4. Remuneration matters, including the Remuneration Policy and remuneration report for approval.

  5. Election of members of the Board of Directors.

  6. Appointment of auditors.

  7. Any other business.

The agenda of the Company's general meeting and the complete proposals, its updated Remuneration Policy, remuneration report, as well as its Annual Report have been submitted to Nykredit A/S, which owns all the shares of the Company.

Item5ontheagenda proposes re-election of Merete Eldrup, Michael Demsitz, Per
W. Hallgren, Jørgen Høholt, Vibeke Krag, Mie Krog and Preben Sunke and election of Torsten H. Jørgensen. Hans-Ole Jochumsen has announced that he will not seek re- election to the Board of Directors.

Nykredit Realkredit A/S CVR no 12 71 92 80

Nykredit Realkredit A/S Kalvebod Brygge 1-3 DK-1560 Copenhagen V Tel +45 44 55 10 00
www.nykredit.com

Torsten H. Jørgensen is CEO of Nets A/S and Head of Issuing Solutions, EVP at Nexigroup Spa. Torsten H. Jørgensen has, among other things, previously served as Deputy CEO, Group COO, Group CFO and Head of Group Operations & Other Lines of Business at Nordea Bank AB. Torsten H. Jørgensen has also served as Director at Danske Markets, and holds a MSc (Economics) from the University of Copenhagen (1991).

As item 6 on the agenda the Board of Directors proposes re-appointment of EY Godkendt Revisionspartnerselskab as auditors of the Company as recommended by the Board Audit Committee.

Admittance to the general meeting is subject to collection of an admission card at least three days prior to the general meeting.

Copenhagen,9March2023

Nykredit Realkredit A/S Board of Directors

Contact:
QuestionsmaybeaddressedtoPressRelations,tel+4527589588.

Page 2/2

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Oxurion Publishes 2022 Annual Report31.3.2023 20:42:16 CEST | Press release

Regulated Information Leuven, BELGIUM,Boston, MA, US–March 31, 2023– 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, published its annual report for the financial year 2022. The annual report for the year ending December 31, 2022 is available in the “Investors” section of the Company’s website, and can also be downloaded as a PDF. About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeut

Nokia Corporation: Repurchase of own shares on 31.03.202331.3.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 31 March 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 31.03.2023 Espoo, Finland – On 31 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL221,1864.49CEUX21,0654.50AQEU12,3894.49TQEX7,3604.50Total262,0004.49 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 a

Fly Play hf.: Amendments to share option plan31.3.2023 20:00:00 CEST | Press release

Amendments to share option plan As detailed in the Company Description in relation to the listing of shares in Fly Play hf. on Nasdaq First North Iceland, dated June 2021, the Company had, in accordance with the remuneration then in force, implemented a share-based incentive program in the form of option rights whereby the Company granted several members of the management team and other key employees options to purchase shares in the Company as part of their remuneration. Having regard for the purposes of the share-based incentive program referred to above, the Board of Directors has decided to extend the exercise period in relation to share options to purchase a total of 16.666.669 shares in the Company, at a purchase price of ISK 8 per share. For a period of 12 months, these options are therefore exercisable until April 2024, at which point the options expire. The options may be exercised at any time during the exercise period.

SBM Offshore completes US$1.63 billion financing of Almirante Tamandaré31.3.2023 19:25:15 CEST | Press release

March 31, 2023 SBM Offshore is pleased to announce it has signed the project financing of FPSO Almirante Tamandaré for a total of US$1.63 billion. The project financing is provided by a consortium of 13 international banks with insurance cover from 4 international Export Credit Agencies (ECA). The financing is composed of five separate facilities with a ca. 6.3% weighted average cost of debt and a 14-year post-completion maturity for both the ECA covered facilities and the uncovered facility. The FPSO’s design incorporates SBM Offshore’s industry leading Fast4Ward® new build, multi-purpose hull. It will be the largest oil producing unit in Brazil with a processing capacity of 225,000 barrels of oil and 12 million m3 of gas per day. The FPSO will have an estimated greenhouse gas (GHG) emission intensity below 10 kgCO2e/boe1 and will benefit from emission reduction technologies such as the closed flare technology which increases gas utilization, preventing it from being burnt into the at